Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Caffeine Modulates Food Intake Depending on the Context That Gives Access to Food: Comparison With Dopamine Depletion.

Correa M, SanMiguel N, López-Cruz L, Carratalá-Ros C, Olivares-García R, Salamone JD.

Front Psychiatry. 2018 Sep 6;9:411. doi: 10.3389/fpsyt.2018.00411. eCollection 2018.

2.

The Psychopharmacology of Effort-Related Decision Making: Dopamine, Adenosine, and Insights into the Neurochemistry of Motivation.

Salamone JD, Correa M, Ferrigno S, Yang JH, Rotolo RA, Presby RE.

Pharmacol Rev. 2018 Oct;70(4):747-762. doi: 10.1124/pr.117.015107. Review.

PMID:
30209181
3.

Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.

López-Cruz L, Salamone JD, Correa M.

Front Pharmacol. 2018 Jun 1;9:526. doi: 10.3389/fphar.2018.00526. eCollection 2018. Review.

4.

Editorial: Ethanol, Its Active Metabolites, and Their Mechanisms of Action: Neurophysiological and Behavioral Effects.

Acquas E, Salamone JD, Correa M.

Front Behav Neurosci. 2018 May 17;12:95. doi: 10.3389/fnbeh.2018.00095. eCollection 2018. No abstract available.

5.

Individual differences in the energizing effects of caffeine on effort-based decision-making tests in rats.

SanMiguel N, Pardo M, Carratalá-Ros C, López-Cruz L, Salamone JD, Correa M.

Pharmacol Biochem Behav. 2018 Jun;169:27-34. doi: 10.1016/j.pbb.2018.04.004. Epub 2018 Apr 13.

PMID:
29655598
6.

Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research.

Salamone JD, Correa M, Yang JH, Rotolo R, Presby R.

Front Behav Neurosci. 2018 Mar 23;12:52. doi: 10.3389/fnbeh.2018.00052. eCollection 2018. Review.

7.

Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral striatum DARPP32 phosphorylation patterns.

López-Cruz L, San Miguel N, Carratalá-Ros C, Monferrer L, Salamone JD, Correa M.

Neuropharmacology. 2018 Aug;138:349-359. doi: 10.1016/j.neuropharm.2018.01.034. Epub 2018 Jun 27.

PMID:
29408363
8.

DA Neurons Promote the Instigation and Maintenance of Effortful Responding: A Commentary on Fischbach-Weiss, Reese, and Janak.

Salamone JD.

Neuroscience. 2018 Feb 21;372:316. doi: 10.1016/j.neuroscience.2018.01.019. Epub 2018 Jan 12. No abstract available.

PMID:
29337232
9.

Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions.

Contreras-Mora H, Rowland MA, Yohn SE, Correa M, Salamone JD.

Pharmacol Biochem Behav. 2018 Mar;166:13-20. doi: 10.1016/j.pbb.2018.01.001. Epub 2018 Jan 6.

PMID:
29309800
10.

The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions.

Yohn SE, Reynolds S, Tripodi G, Correa M, Salamone JD.

Behav Brain Res. 2018 Apr 16;342:27-34. doi: 10.1016/j.bbr.2017.12.039. Epub 2017 Dec 29.

PMID:
29292157
11.

Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression.

Yohn SE, Gorka D, Mistry A, Collins S, Qian E, Correa M, Manchanda A, Bogner RH, Salamone JD.

J Nat Prod. 2017 Oct 27;80(10):2839-2844. doi: 10.1021/acs.jnatprod.7b00425. Epub 2017 Sep 14.

PMID:
28905625
12.

Stress and chronic illness: The inflammatory pathway.

Acabchuk RL, Kamath J, Salamone JD, Johnson BT.

Soc Sci Med. 2017 Jul;185:166-170. doi: 10.1016/j.socscimed.2017.04.039. Epub 2017 Apr 26. No abstract available.

PMID:
28552293
13.

Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.

Yohn SE, Alberati D, Correa M, Salamone JD.

Psychopharmacology (Berl). 2017 May;234(9-10):1525-1534. doi: 10.1007/s00213-016-4523-3. Epub 2017 Jan 12.

PMID:
28083675
14.

Adenosine A2A receptor deletion affects social behaviors and anxiety in mice: Involvement of anterior cingulate cortex and amygdala.

López-Cruz L, Carbó-Gas M, Pardo M, Bayarri P, Valverde O, Ledent C, Salamone JD, Correa M.

Behav Brain Res. 2017 Mar 15;321:8-17. doi: 10.1016/j.bbr.2016.12.020. Epub 2016 Dec 19.

PMID:
28007538
15.

Ethanol and Caffeine Effects on Social Interaction and Recognition in Mice: Involvement of Adenosine A2A and A1 Receptors.

López-Cruz L, San-Miguel N, Bayarri P, Baqi Y, Müller CE, Salamone JD, Correa M.

Front Behav Neurosci. 2016 Nov 2;10:206. eCollection 2016.

16.

Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.

Yohn SE, Arif Y, Haley A, Tripodi G, Baqi Y, Müller CE, Miguel NS, Correa M, Salamone JD.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3575-86. doi: 10.1007/s00213-016-4392-9. Epub 2016 Aug 6.

PMID:
27497935
17.

Subthalamic and Cortical Local Field Potentials Associated with Pilocarpine-Induced Oral Tremor in the Rat.

Long LL, Podurgiel SJ, Haque AF, Errante EL, Chrobak JJ, Salamone JD.

Front Behav Neurosci. 2016 Jun 17;10:123. doi: 10.3389/fnbeh.2016.00123. eCollection 2016.

18.

Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology.

Yohn SE, Errante EE, Rosenbloom-Snow A, Somerville M, Rowland M, Tokarski K, Zafar N, Correa M, Salamone JD.

Neuropharmacology. 2016 Oct;109:270-280. doi: 10.1016/j.neuropharm.2016.06.018. Epub 2016 Jun 18.

PMID:
27329556
19.

Evaluation of the effort-related motivational effects of the novel dopamine uptake inhibitor PRX-14040.

Yohn SE, Gogoj A, Haque A, Lopez-Cruz L, Haley A, Huxley P, Baskin P, Correa M, Salamone JD.

Pharmacol Biochem Behav. 2016 Sep;148:84-91. doi: 10.1016/j.pbb.2016.06.004. Epub 2016 Jun 11. No abstract available.

PMID:
27296079
20.

Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.

Salamone JD, Yohn SE, López-Cruz L, San Miguel N, Correa M.

Brain. 2016 May;139(Pt 5):1325-47. doi: 10.1093/brain/aww050. Review.

21.

The pharmacology of effort-related choice behavior: Dopamine, depression, and individual differences.

Salamone JD, Correa M, Yohn S, Lopez Cruz L, San Miguel N, Alatorre L.

Behav Processes. 2016 Jun;127:3-17. doi: 10.1016/j.beproc.2016.02.008. Epub 2016 Feb 19. Review.

PMID:
26899746
22.

Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.

Yohn SE, Lopez-Cruz L, Hutson PH, Correa M, Salamone JD.

Psychopharmacology (Berl). 2016 Mar;233(6):949-60. doi: 10.1007/s00213-015-4176-7. Epub 2015 Dec 23.

PMID:
26694811
23.

The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine.

Podurgiel SJ, Yohn SE, Dortche K, Correa M, Salamone JD.

Behav Brain Res. 2016 Feb 1;298(Pt B):188-91. doi: 10.1016/j.bbr.2015.11.008. Epub 2015 Nov 15.

PMID:
26590367
24.

Choosing voluntary exercise over sucrose consumption depends upon dopamine transmission: effects of haloperidol in wild type and adenosine A₂AKO mice.

Correa M, Pardo M, Bayarri P, López-Cruz L, San Miguel N, Valverde O, Ledent C, Salamone JD.

Psychopharmacology (Berl). 2016 Feb;233(3):393-404. doi: 10.1007/s00213-015-4127-3. Epub 2015 Nov 10.

PMID:
26554387
25.

Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.

Podurgiel SJ, Spencer T, Kovner R, Baqi Y, Müller CE, Correa M, Salamone JD.

Pharmacol Biochem Behav. 2016 Jan;140:62-7. doi: 10.1016/j.pbb.2015.10.008. Epub 2015 Oct 13.

PMID:
26459156
26.

Mesolimbic Dopamine and the Regulation of Motivated Behavior.

Salamone JD, Pardo M, Yohn SE, López-Cruz L, SanMiguel N, Correa M.

Curr Top Behav Neurosci. 2016;27:231-57. doi: 10.1007/7854_2015_383. Review.

PMID:
26323245
27.

Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.

Yohn SE, Collins SL, Contreras-Mora HM, Errante EL, Rowland MA, Correa M, Salamone JD.

Neuropsychopharmacology. 2016 Feb;41(3):686-94. doi: 10.1038/npp.2015.188. Epub 2015 Jun 24.

28.

The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists.

Yohn SE, Santerre JL, Nunes EJ, Kozak R, Podurgiel SJ, Correa M, Salamone JD.

Pharmacol Biochem Behav. 2015 Aug;135:217-26. doi: 10.1016/j.pbb.2015.05.003. Epub 2015 May 29.

PMID:
26022661
29.

Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism.

Podurgiel SJ, Milligan MN, Yohn SE, Purcell LJ, Contreras-Mora HM, Correa M, Salamone JD.

Neuropsychopharmacology. 2015 Aug;40(9):2240-7. doi: 10.1038/npp.2015.69. Epub 2015 Mar 11.

30.

Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, and D3 receptor antagonists.

Pardo M, López-Cruz L, San Miguel N, Salamone JD, Correa M.

Psychopharmacology (Berl). 2015 Jul;232(13):2377-91. doi: 10.1007/s00213-015-3872-7. Epub 2015 Feb 3.

PMID:
25647696
31.

Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.

Randall PA, Lee CA, Podurgiel SJ, Hart E, Yohn SE, Jones M, Rowland M, López-Cruz L, Correa M, Salamone JD.

Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu017. doi: 10.1093/ijnp/pyu017.

32.

Neurobiological basis of motivational deficits in psychopathology.

Salamone JD, Koychev I, Correa M, McGuire P.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1225-38. doi: 10.1016/j.euroneuro.2014.08.014. Epub 2014 Sep 1. Review.

PMID:
25435083
33.

The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.

Yohn SE, Thompson C, Randall PA, Lee CA, Müller CE, Baqi Y, Correa M, Salamone JD.

Psychopharmacology (Berl). 2015 Apr;232(7):1313-23. doi: 10.1007/s00213-014-3766-0. Epub 2014 Oct 17.

PMID:
25323625
34.

The renaissance of acetaldehyde as a psychoactive compound: decades in the making.

Correa M, Acquas E, Salamone JD.

Front Behav Neurosci. 2014 Jul 22;8:249. doi: 10.3389/fnbeh.2014.00249. eCollection 2014. No abstract available.

35.

The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.

Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B, Shah P, Pandit S, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD.

PLoS One. 2014 Jun 17;9(6):e99320. doi: 10.1371/journal.pone.0099320. eCollection 2014.

36.

Differences between the nonselective adenosine receptor antagonists caffeine and theophylline in motor and mood effects: studies using medium to high doses in animal models.

López-Cruz L, Pardo M, Salamone JD, Correa M.

Behav Brain Res. 2014 Aug 15;270:213-22. doi: 10.1016/j.bbr.2014.05.020. Epub 2014 May 22.

PMID:
24859174
37.
38.

Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.

Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y, Müller CE, López-Cruz L, Correa M, Salamone JD.

J Neurosci. 2013 Dec 4;33(49):19120-30. doi: 10.1523/JNEUROSCI.2730-13.2013.

39.

Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task.

Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA, Baqi Y, Müller CE, Correa M, Salamone JD.

Psychopharmacology (Berl). 2014 Feb;231(4):727-36. doi: 10.1007/s00213-013-3285-4. Epub 2013 Oct 18.

40.

Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia.

Markou A, Salamone JD, Bussey TJ, Mar AC, Brunner D, Gilmour G, Balsam P.

Neurosci Biobehav Rev. 2013 Nov;37(9 Pt B):2149-65. doi: 10.1016/j.neubiorev.2013.08.007. Epub 2013 Aug 28. Review.

41.

The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.

Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD.

Neuroscience. 2013 Oct 10;250:507-19. doi: 10.1016/j.neuroscience.2013.07.008. Epub 2013 Jul 15.

PMID:
23867769
42.

Acetate as an active metabolite of ethanol: studies of locomotion, loss of righting reflex, and anxiety in rodents.

Pardo M, Betz AJ, San Miguel N, López-Cruz L, Salamone JD, Correa M.

Front Behav Neurosci. 2013 Jul 10;7:81. doi: 10.3389/fnbeh.2013.00081. eCollection 2013.

43.

c-Fos immunoreactivity in prefrontal, basal ganglia and limbic areas of the rat brain after central and peripheral administration of ethanol and its metabolite acetaldehyde.

Segovia KN, Vontell R, López-Cruz L, Salamone JD, Correa M.

Front Behav Neurosci. 2013 May 24;7:48. doi: 10.3389/fnbeh.2013.00048. eCollection 2013.

44.

Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054.

McLaughlin PJ, Thakur GA, Vemuri VK, McClure ED, Brown CM, Winston KM, Wood JT, Makriyannis A, Salamone JD.

Pharmacol Biochem Behav. 2013 Aug;109:16-22. doi: 10.1016/j.pbb.2013.04.011. Epub 2013 Apr 19.

45.

Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.

Collins-Praino LE, Paul NE, Ledgard F, Podurgiel SJ, Kovner R, Baqi Y, Müller CE, Senatus PB, Salamone JD.

Eur J Neurosci. 2013 Jul;38(1):2183-91. doi: 10.1111/ejn.12212. Epub 2013 Apr 18.

PMID:
23600953
46.

Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors.

Nunes EJ, Randall PA, Podurgiel S, Correa M, Salamone JD.

Neurosci Biobehav Rev. 2013 Nov;37(9 Pt A):2015-25. doi: 10.1016/j.neubiorev.2013.04.002. Epub 2013 Apr 10. Review.

PMID:
23583616
47.

Insulin and ventral tegmental dopamine: what's impaired and what's intact?

Salamone JD, Correa M.

Cell Metab. 2013 Apr 2;17(4):469-70. doi: 10.1016/j.cmet.2013.03.011.

48.

Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice.

Pardo M, López-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M.

Behav Brain Res. 2013 Jun 15;247:217-26. doi: 10.1016/j.bbr.2013.03.035. Epub 2013 Apr 1.

PMID:
23557694
49.

Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.

Podurgiel S, Collins-Praino LE, Yohn S, Randall PA, Roach A, Lobianco C, Salamone JD.

Pharmacol Biochem Behav. 2013 Apr;105:105-11. doi: 10.1016/j.pbb.2013.01.015. Epub 2013 Jan 27.

PMID:
23360954
50.

Dopamine and food addiction: lexicon badly needed.

Salamone JD, Correa M.

Biol Psychiatry. 2013 May 1;73(9):e15-24. doi: 10.1016/j.biopsych.2012.09.027. Epub 2012 Nov 22. Review.

Supplemental Content

Loading ...
Support Center